- Home
- TVGN vs FEIM Comparison
TVGN vs FEIM Comparison
Compare TVGN & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVGN
- FEIM
- Stock Information
- Founded
- TVGN 2020
- FEIM 1961
- Country
- TVGN United States
- FEIM United States
- Employees
- TVGN N/A
- FEIM N/A
- Industry
- TVGN Blank Checks
- FEIM Electrical Products
- Sector
- TVGN Finance
- FEIM Industrials
- Exchange
- TVGN Nasdaq
- FEIM Nasdaq
- Market Cap
- TVGN 198.6M
- FEIM 173.6M
- IPO Year
- TVGN N/A
- FEIM N/A
- Fundamental
- Price
- TVGN $0.98
- FEIM $17.28
- Analyst Decision
- TVGN Strong Buy
- FEIM
- Analyst Count
- TVGN 1
- FEIM 0
- Target Price
- TVGN $10.00
- FEIM N/A
- AVG Volume (30 Days)
- TVGN 528.6K
- FEIM 49.9K
- Earning Date
- TVGN 05-28-2025
- FEIM 03-13-2025
- Dividend Yield
- TVGN N/A
- FEIM 5.81%
- EPS Growth
- TVGN N/A
- FEIM 604.98
- EPS
- TVGN N/A
- FEIM 2.41
- Revenue
- TVGN N/A
- FEIM $65,400,999.00
- Revenue This Year
- TVGN N/A
- FEIM N/A
- Revenue Next Year
- TVGN N/A
- FEIM N/A
- P/E Ratio
- TVGN N/A
- FEIM $7.16
- Revenue Growth
- TVGN N/A
- FEIM 24.10
- 52 Week Low
- TVGN $0.26
- FEIM $8.62
- 52 Week High
- TVGN $3.09
- FEIM $20.33
- Technical
- Relative Strength Index (RSI)
- TVGN 40.84
- FEIM 61.16
- Support Level
- TVGN $0.93
- FEIM $16.59
- Resistance Level
- TVGN $1.13
- FEIM $17.00
- Average True Range (ATR)
- TVGN 0.11
- FEIM 0.86
- MACD
- TVGN 0.00
- FEIM 0.19
- Stochastic Oscillator
- TVGN 25.00
- FEIM 95.03
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
About FEIM Frequency Electronics Inc.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.